
Commentary|Videos|February 12, 2025
Improving Clinical Trials Through Inclusion, Access, and Engagement
Fact checked by: Jordyn Sava
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss potential strategies that teams can implement to ensure clinical trials are more representative of the general population.
Advertisement
Mariam F. Eskander, MD, MPH, assistant professor of surgery and a gastrointestinal surgical oncologist at the Rutgers Cancer Institute, and Coral O. Omene, MD, PhD, an associate professor of medicine, breast medical oncologist, and program director for breast cancer disparities research at Rutgers Cancer Institute, discuss potential long-term, sustainable strategies that teams can implement to ensure clinical trials are more representative of the general population, and how that may differ between academic and community oncology settings.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Subcostal Robotic Surgery Cuts Thoracic Pain
2
FDA Grants Final Approval to Cabozantinib Capsule Formulation
3
Risk-Adapted Quadruplet Therapy Sustains 5-Year Survival Benefit in High-Risk Myeloma
4
David DiBardino, MD, on the Rationale for Intratumoral Therapy in Lung Cancer
5











































